Related Experiment Video

Updated: Aug 9, 2026

Continuous Fluorescence-Based Endonuclease-Coupled DNA Methylation Assay to Screen for DNA Methyltransferase Inhibitors
06:07

Continuous Fluorescence-Based Endonuclease-Coupled DNA Methylation Assay to Screen for DNA Methyltransferase Inhibitors

Published on: August 5, 2022

Therapeutic implications of DNA methylation

Moshe Szyf1

  • 1Department of Pharmacology and Therapeutics, McGill University, 3655 Sir William Osler Promenade, Montreal, PQ H3G 1Y6, Canada. moshe.szyf@mcgill.ca

Future Oncology (London, England)
|March 25, 2006
PubMed

Insights

Cancer epigenome alterations, including DNA hypomethylation and hypermethylation, drive tumor growth. Understanding these epigenetic changes is key to developing targeted therapies that can reverse cancer progression.

Area of Science:

  • Epigenetics
  • Cancer Biology
  • Molecular Oncology

Background:

  • Cancer progression involves significant gene expression reprogramming.
  • The epigenome, including DNA methylation, governs gene expression patterns.
  • Cancer cells exhibit aberrant DNA methylation, with both hypo- and hypermethylation.

Purpose of the Study:

  • To investigate the role of aberrant DNA methylation in cancer growth and metastasis.
  • To explore the potential of DNA methylation-targeted drugs as cancer therapeutics.
  • To address the challenge of balancing epigenetic modifications for effective cancer treatment.

Main Methods:

  • Analysis of DNA methylation patterns in cancer cells.
  • Investigation of DNA methylation enzyme regulation in cancer.
  • Pharmacological manipulation of DNA methylation patterns.

Main Results:

  • Cancer epigenomes show widespread DNA methylation aberrations (hypo- and hypermethylation).
  • Aberrant regulation of DNA methylation enzymes is observed in cancer.
  • Pharmacological agents show potential to alter DNA methylation and impact cancer growth.

Conclusions:

  • Epigenetic dysregulation, specifically DNA methylation changes, is a hallmark of cancer.
  • Targeting DNA methylation offers a promising therapeutic avenue for reversing cancer growth and metastasis.
  • Further research is needed to balance epigenetic therapies for optimal outcomes and minimized side effects.

More Related Videos

Immunostaining for DNA Modifications: Computational Analysis of Confocal Images09:42

Immunostaining for DNA Modifications: Computational Analysis of Confocal Images

Published on: September 7, 2017

Enhanced Reduced Representation Bisulfite Sequencing for Assessment of DNA Methylation at Base Pair Resolution13:47

Enhanced Reduced Representation Bisulfite Sequencing for Assessment of DNA Methylation at Base Pair Resolution

Published on: February 24, 2015

Related Concept Videos

Epigenetic Regulation01:37

Epigenetic Regulation

Epigenetic changes alter the physical structure of the DNA without changing the genetic sequence and often regulate whether genes are turned on or off. This regulation ensures that each cell produces only proteins necessary for its function. For example, proteins that promote bone growth are not produced in muscle cells. Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
X-chromosome...
Epigenetic Regulation01:46

Epigenetic Regulation

Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
Phase II Reactions: Methylation Reactions01:17

Phase II Reactions: Methylation Reactions

Methylation is a phase II biotransformation process involving the attachment of a methyl group to a substrate. Enzymes known as methyltransferases orchestrate this reaction.
The mechanism of methylation unfolds in two stages. The first stage sees a methyltransferase enzyme facilitating the transfer of a methyl group from S-adenosylmethionine (SAM) to the substrate, forming S-adenosylhomocysteine (SAH). The second stage involves further metabolism of SAH into homocysteine, which can be recycled...
Biosynthesis of Nucleic Acids01:28

Biosynthesis of Nucleic Acids

Nucleic acid biosynthesis is a fundamental biochemical process that produces the purine and pyrimidine nucleotides essential for DNA and RNA synthesis. This pathway maintains a balanced nucleotide pool, preventing imbalances that could jeopardize genetic integrity and cellular function. Given the crucial role of nucleotides, their synthesis is tightly regulated to ensure proper cellular homeostasis.Purine BiosynthesisThe biosynthesis of purine nucleotides begins with ribose-5-phosphate, a...
Genomic Imprinting and Inheritance02:30

Genomic Imprinting and Inheritance

Diploid organisms inherit genetic material through chromosomes from both parents. Copies of the same gene are known as alleles. In most cases, both alleles are simultaneously expressed and allow various cellular processes to function optimally. If one of the alleles is missing or mutated, the expression of the other allele can compensate; however, this is not true for all genes.
The expression of some genes depends on which parent passed the gene to the offspring, through a phenomenon known as...
Inheritance of Chromatin Structures03:17

Inheritance of Chromatin Structures

Epigenetics is the study of inherited changes in a cell's phenotype without changing the DNA sequences. It provides a form of memory for the differential gene expression pattern to maintain cell lineage, position-effect variegation, dosage compensation, and maintenance of chromatin structures such as telomeres and centromeres. For example, the structure and location of the centromere on chromosomes are epigenetically inherited. Its functionality is not dictated or ensured by the underlying DNA...